Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma (NCT04685616)
OrganizationBiotech
University College, London
Organization linked by public source evidence.
Public IDs
No public external ID is attached.
Related people
No reviewed person affiliation is attached.
Outputs
No reviewed output is linked through affiliated people.
Topics
Relationship evidence
Timeline
No dated relationship evidence is attached.